Search Medical Condition
Please enter condition
Please choose location from dropdown

Shreveport, Louisiana Clinical Trials

A listing of Shreveport, Louisiana clinical trials actively recruiting patient volunteers.

RESULTS

Found (193) clinical trials

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Phase N/A

1.48 miles

Learn More »

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

This is a Phase II trial assessing the safety and preliminary efficacy of daily APL-2 subcutaneous infusion administered for 16 weeks with a 6 month safety follow up, in patients with glomerulopathies

Phase

1.48 miles

Learn More »

Confirmatory Clinical Study of Oxiplex

This is a prospective, multi-center, randomized, controlled, patient and evaluator-blinded clinical study to assess the safety and effectiveness for the reduction of pain and symptoms following lumbar surgery.

Phase N/A

1.48 miles

Learn More »

Study to Evaluate the Safety and Preliminary Efficacy of IDCT a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

This is a Phase I, firstinhuman, randomized, doubleblind, vehicle and placebo-controlled, parallelgroup, multi-center study in subjects with singlelevel, symptomatic lumbar intervertebral disc degeneration (>6 months) and unresponsive to conservative therapy for at least 3 months. The study will compare single intradiscal injections of high and low dose IDCT with two ...

Phase

1.48 miles

Learn More »

Study of Nucel for One and Two Level Lumbar Interbody Fusion

Two hundred non-randomized subjects will participate in the study at up to ten clinical sites in the United States. Participants will be between 18 and 75 years of age. All subjects will have been established with lumbar spine disease at one or two levels of the lumbar spine that requires ...

Phase N/A

1.48 miles

Learn More »

A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

The duration of treatment for each patient will be determined by the clinical need for parenteral opioid therapy. Eligible patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with ...

Phase

1.48 miles

Learn More »

An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)

The study consists of a screening visit, a wash out period of up to 3 weeks, when existing phosphate lowering medication is withheld, an 8-week treatment period, in which all groups receive tenapanor, and a 4-week placebo-controlled, randomized withdrawal period, during which patients are re-randomized 1:1 to either remain on ...

Phase

1.48 miles

Learn More »

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

The main objective of this trial is the safety and tolerability of 3 multiple rising oral doses of BI 685509 over 28 days in male and female patients with Diabetic Nephropathy (DN) as adjunctive to Angiotensin Converting Enzyme inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB). Another objective is the change ...

Phase

1.48 miles

Learn More »

Post-Approval 'Real Conditions of Use' Study

The first objective of this trial is to evaluate 5-year clinical status of patients implanted with the coflex device in conjunction with surgical decompression relative to decompression alone. The composite primary endpoint for this objective is in three parts: 1) At least a 15 point improvement relative to pretreatment baseline ...

Phase N/A

1.48 miles

Learn More »

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON

This international, multi-center, randomized, double-blind, placebo-controlled Phase 3 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients with ADPKD. Patients will be randomized 1:1 to either bardoxolone methyl or placebo. Patients receiving bardoxolone methyl will start with once-daily dosing at 5 mg and will dose-escalate ...

Phase

1.48 miles

Learn More »